Literature DB >> 9502832

Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity.

R E Hampson1, G Rogers, G Lynch, S A Deadwyler.   

Abstract

In the companion article (Hampson et al., 1998), the ampakine CX516 (Cortex Pharmaceuticals) was shown to produce a marked facilitation of performance of a spatial delayed-nonmatch-to-sample (DNMS) task in rats. Injections of the drug before each daily session produced a marked and progressive improvement in performance at longer delays (>5 sec) that persisted for 7 d after drug treatment was terminated. In most animals (n = 9) the increase in performance carried over to the intervening vehicle for days, whereas in others (n = 3) the effects dissipated within the session according to the pharmacological half-life of CX516. In this article we report firing correlates of simultaneously recorded cells in the CA1 and CA3 fields of the hippocampus over the period in which DNMS performance was facilitated by CX516. Sample and Delay period firing was enhanced by 100-350% under CX516 and increased progressively over days as did DNMS performance. The firing increases were restricted to correct trials only and were largest on trials with long delays. Firing in the intertrial interval was also altered, but in a manner consistent with a previously demonstrated reduction in between-trial proactive interference by CX516. Finally, in animals in which the effects of CX516 were restricted to when the drug was actually present (i.e., no carryover effects), increased cell firing also paralleled the time course of the performance increase. Results are discussed with respect to the actions of ampakines on hippocampal cellular and synaptic processes that underlie DNMS performance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502832      PMCID: PMC6793114     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  A neural mechanism for working and recognition memory in inferior temporal cortex.

Authors:  E K Miller; L Li; R Desimone
Journal:  Science       Date:  1991-11-29       Impact factor: 47.728

2.  Spatial distribution of potentiated synapses in hippocampus: dependence on cellular mechanisms and network properties.

Authors:  M F Yeckel; T W Berger
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

3.  Single neuron activity in human hippocampus and amygdala during recognition of faces and objects.

Authors:  I Fried; K A MacDonald; C L Wilson
Journal:  Neuron       Date:  1997-05       Impact factor: 17.173

4.  Responses of hippocampal formation neurons in the monkey related to delayed spatial response and object-place memory tasks.

Authors:  P M Cahusac; Y Miyashita; E T Rolls
Journal:  Behav Brain Res       Date:  1989-07-01       Impact factor: 3.332

5.  Structural determinants of allosteric regulation in alternatively spliced AMPA receptors.

Authors:  K M Partin; D Bowie; M L Mayer
Journal:  Neuron       Date:  1995-04       Impact factor: 17.173

6.  Responses of single neurons in the hippocampus of the macaque related to recognition memory.

Authors:  E T Rolls; P M Cahusac; J D Feigenbaum; Y Miyashita
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo.

Authors:  U Stäubli; Y Perez; F B Xu; G Rogers; M Ingvar; S Stone-Elander; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Facilitation of glutamate receptors reverses an age-associated memory impairment in rats.

Authors:  R Granger; S Deadwyler; M Davis; B Moskovitz; M Kessler; G Rogers; G Lynch
Journal:  Synapse       Date:  1996-04       Impact factor: 2.562

9.  Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.

Authors:  R E Hampson; G Rogers; G Lynch; S A Deadwyler
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

10.  Effect of thiocyanate on AMPA receptor mediated responses in excised patches and hippocampal slices.

Authors:  A Arai; J Silberg; M Kessler; G Lynch
Journal:  Neuroscience       Date:  1995-06       Impact factor: 3.590

View more
  32 in total

1.  A desensitization-selective potentiator of AMPA-type glutamate receptors.

Authors:  Masayuki Sekiguchi; Kaori Nishikawa; Shunsuke Aoki; Keiji Wada
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

Review 2.  The treatment of cognitive impairment in schizophrenia.

Authors:  Donald C Goff; Michele Hill; Deanna Barch
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

3.  Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans.

Authors:  Ye Wu; Amy C Arai; Gavin Rumbaugh; Anand K Srivastava; Gillian Turner; Takashi Hayashi; Erika Suzuki; Yuwu Jiang; Lilei Zhang; Jayson Rodriguez; Jackie Boyle; Patrick Tarpey; F Lucy Raymond; Joke Nevelsteen; Guy Froyen; Mike Stratton; Andy Futreal; Jozef Gecz; Roger Stevenson; Charles E Schwartz; David Valle; Richard L Huganir; Tao Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

Review 4.  Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders.

Authors:  Stefano Marenco; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.

Authors:  M L Woolley; K A Waters; J E Gartlon; L P Lacroix; C Jennings; F Shaughnessy; A Ong; D J Pemberton; M H Harries; E Southam; D N C Jones; L A Dawson
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

6.  Rational Design of a Novel AMPA Receptor Modulator through a Hybridization Approach.

Authors:  Nicola Caldwell; Jonathan E Harms; Kathryn M Partin; Craig Jamieson
Journal:  ACS Med Chem Lett       Date:  2015-02-11       Impact factor: 4.345

7.  AMPAKINE enhancement of social interaction in the BTBR mouse model of autism.

Authors:  J L Silverman; C F Oliver; M N Karras; P T Gastrell; J N Crawley
Journal:  Neuropharmacology       Date:  2012-07-16       Impact factor: 5.250

8.  Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons.

Authors:  J C Lauterborn; G Lynch; P Vanderklish; A Arai; C M Gall
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

9.  Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression.

Authors:  J C Lauterborn; E Pineda; L Y Chen; E A Ramirez; G Lynch; C M Gall
Journal:  Neuroscience       Date:  2008-12-24       Impact factor: 3.590

10.  Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717.

Authors:  R E Hampson; R A España; G A Rogers; L J Porrino; S A Deadwyler
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.